摘要
目的 探讨17β-雌二醇对甲状腺癌细胞增殖的影响,及其与三叶因子3(TFF3)基因启动子甲基化水平的关系。方法 将甲状腺癌TPC-1、BCPAP、FTC-133细胞分为4组:空白组(未加任何处理)、对照组(含浓度<0.05%二甲基亚砜的培养基)和低、高剂量实验组(1和100 nmol·L^(-1) 17β-雌二醇)。用甲基化特异性聚合酶链反应分析17β-雌二醇处理前后3株细胞TFF3基因启动子区甲基化水平,用生长曲线检测17β-雌二醇对3株细胞增殖的影响。结果 TFF3基因启动子甲基化水平随17β-雌二醇浓度的升高而降低。在TPC-1细胞中,低、高剂量实验组的TFF3基因启动子区甲基化百分比分别从空白组和对照组的(53.34±0.62)%,(54.62±3.11)%降至(37.12±1.19)%和(27.84±0.73)%,BCPAP细胞的TFF3基因启动子区甲基化百分比从空白组和对照组的(56.04±0.93)%,(58.08±0.89)%降至(50.33±0.55)%和(26.36±0.74)%,FTC-133细胞的TFF3基因启动子区甲基化百分从空白组和对照组的(73.28±0.36)%,(71.64±0.54)%降至(61.33±0.56)%和(51.28±0.62)%。在3种细胞中,低、高剂量实验组的上述指标与对照组相比,差异均有统计学意义(P<0.05,P<0.01)。生长曲线结果显示,17β-雌二醇能促进甲状腺癌细胞增殖。对照组在第5天时TPC-1,BCPAP和FTC-133细胞的汇合度分别为(50.04±2.83)%,(30.02±4.97)%和(25.09±2.94)%,高剂量实验组在第5天时TPC-1,BCPAP和FTC-133细胞的汇合度分别上升到(100.00±2.16)%,(90.08±3.56)%和(40.03±2.93)%,高剂量实验组的上述指标与对照组相比,差异均有统计学意义(均P<0.01)。结论 17β-雌二醇能通过降低TFF3基因启动子区CPG位点的DNA甲基化水平,促进癌细胞增殖。
Objective To investigate the effect of 17β-estradiol on proliferation of thyroid cancer (TC) cells,and to explore its relationship with the methylation levels of trefoil family factor 3 (TFF3) promoter in different TC cell lines.Methods The 3 types of TC cells,TPC-1,BCPAP and FTC-133 were divided into 4 groups:blank group (without any treatment),control group (media containing<0.05%dimethylsulfoxide),experimental-L group (1 nmol·L^(-1)) and experimental-H group (100 nmol·L^(-1)).The methylation levels of TFF3 gene promoter region of TC cells before and after 17β-estradiol treatment were analysed by methylation-specific polymerase chain reaction.Growth curve experiment was used to detect the effect of 17β-estradiol on the proliferation of three types of TC cells.Results The methylation level of the TFF3 gene promoter decreased with the increase of 17β-estradiol concentration.In TPC-1 cells,the methylation percentage of TFF3 gene promoter region in blank and control groups were (53.34±0.62)%and (54.62±3.11)%,which in experimental-Land experimental-H groups decreased to (37.12±1.19)%and (27.84±0.73)%,respectively.In BCPAP cells,the methylation percentage of TFF3 gene promoter region in blank and control groups were (56.04±0.93)%and(58.08±0.89)%,which in experimental-L and experimental-H groups decreased to (50.33±0.55)%and(26.36±0.74)%,respectively.In FTC-133 cells,the methylation percentage of TFF3 gene promoter region in blank and control groups were (73.28±0.36)%and (71.64±0.54)%,which in experimental-L and experimental-H groups decreased to (61.33±0.56)%and (51.28±0.62)%,respectively.Among the three cells,the differences of above indexes were statistically significant between the experimental-L,-H groups and control group (P<0.05,P<0.01).The results of growth curve indicated that 17β-estradiol could stimulate the proliferation of thyroid cancer cells.The confluences of TPC-1,BCPAP and FTC-133 cells at the 5^(th)day were(50.04±2.83)%,(30.02±4.97)%,(25.09±2.94)%in blank group,but in group experimental-H,these values rised to (100.00±2.16)%,(90.08±3.56)%,(40.03±2.93)%.Also,there were statistically significant differences between experimental-H group with blank group (all P<0.01).Conclusion 17β-estradiol may promote TC cell proliferation by reducing the DNA methylation level of CPG sites in the promoter region of TFF3 gene.
作者
时瑶
范会利
秦小静
张文静
林旭
张静
薛刚
吴靖芳
SHI Yao;FAN Hui-li;QIN Xiao-jing;ZHANG WEN-jing;LIN Xu;ZHANG Jing;XUE Gang;WU Jing-fang(Morphology Laboratory,Hebei North University,Zhangjiakou 075000,Hebei Province,China;Department of Histology and Embryology,Hebei North University,Zhangjiakou 075000,Hebei Province,China;Department of Otorhinolaryngology Head and Neck Surgery,Hebei North University,Zhangjiakou 075000,Hebei Province,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2023年第4期483-487,共5页
The Chinese Journal of Clinical Pharmacology
基金
河北省自然科学基金资助项目(H2018405054)。
关键词
三叶因子3
甲状腺癌
甲基化
雌激素
雌激素受体Α
细胞增殖
trefoil factor 3
thyroid carcinoma
methylation
estrogen
estrogen receptorα
cell proliferation